Analgesic Consumption in the Early Postoperative Period: A Prospective Observational PACU Study

April 26, 2026 updated by: Mustafa Kemal ŞAHİN, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Factors Influencing Analgesic Consumption in the Early Postoperative Period: A Prospective Observational Study in the Post-Anesthesia Care Unit

Postoperative pain remains a significant clinical challenge that directly affects patient recovery, functional outcomes, and overall quality of care. Inadequate pain control in the early postoperative period is associated with delayed mobilization, increased risk of complications, prolonged hospital stay, and the development of chronic pain. The post-anesthesia care unit (PACU) represents a critical phase in which pain is actively assessed and managed, and analgesic consumption during this period serves as an objective indicator of analgesic requirements and effectiveness of perioperative pain strategies.

This prospective observational study aims to identify patient-related, surgical, and anesthesia-related factors influencing analgesic consumption in the early postoperative period among adult patients admitted to the PACU following elective surgery. No additional interventions will be performed, and all perioperative management will follow routine clinical practice. Data will be collected prospectively from clinical records, anesthesia charts, and PACU monitoring forms.

The primary outcome is total analgesic consumption during the PACU stay. Secondary outcomes include pain intensity assessed using a standardized pain scale at PACU admission and discharge, requirement for rescue analgesia, incidence of postoperative nausea and vomiting, and length of stay in the PACU.

The findings of this study are expected to contribute to the identification of patients at higher risk for increased analgesic requirements and to support the development of individualized pain management strategies, ultimately improving perioperative care quality and patient outcomes.

Study Overview

Detailed Description

Postoperative pain is a major clinical concern that significantly affects recovery, patient satisfaction, and overall perioperative outcomes. Inadequate pain control in the early postoperative period is associated with delayed mobilization, increased risk of complications, prolonged hospital stay, and the development of chronic postoperative pain. Therefore, early identification of factors influencing analgesic requirements is essential for optimizing individualized pain management strategies.

The post-anesthesia care unit (PACU) represents a critical period during which patients are closely monitored following surgery, and pain management is actively adjusted. Analgesic consumption during this phase provides an objective and clinically relevant measure of pain management adequacy. However, analgesic requirements may vary widely depending on patient-related factors (such as age, sex, and body mass index), surgical characteristics (type and duration of surgery), and anesthesia-related variables (anesthetic technique, intraoperative analgesic administration, and use of regional anesthesia).

This study is designed as a single-center, prospective observational study conducted in the post-anesthesia care unit of a tertiary oncology hospital. Adult patients undergoing elective surgical procedures will be included. No additional interventions will be performed, and all perioperative care will be administered according to routine clinical practice. Data will be collected prospectively from anesthesia records, PACU monitoring forms, and hospital electronic systems.

The primary outcome is total analgesic consumption during the PACU stay. Secondary outcomes include pain intensity at PACU admission and discharge, requirement for rescue analgesia, incidence of postoperative nausea and vomiting, and length of stay in the PACU.

The findings of this study are expected to contribute to the identification of patients at higher risk for increased analgesic requirements in the early postoperative period. These results may support the development of individualized and more effective pain management strategies and improve overall perioperative care quality.

Study Type

Observational

Enrollment (Estimated)

254

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Mustafa Kemal Şahin
  • Phone Number: +905075800976
  • Email: mksahin@msn.com

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey (Türkiye), 06200
        • Recruiting
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea
        • Contact:
          • Mustafa Kemal SAHIN, Dr
          • Phone Number: +905075800976
          • Email: mksahin@msn.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients undergoing elective surgical procedures and admitted to the post-anesthesia care unit (PACU) in a tertiary oncology hospital. The study population represents a heterogeneous surgical cohort managed under routine perioperative care conditions.

Description

Inclusion Criteria:

  • Adults aged 18 years and older
  • Undergoing elective surgical procedures
  • Admitted to the post-anesthesia care unit (PACU) after surgery
  • Receiving general and/or regional anesthesia
  • Able to provide informed consent

Exclusion Criteria:

  • Patients younger than 18 years
  • Emergency surgical procedures
  • Patients transferred directly to the intensive care unit postoperatively
  • PACU stay shorter than 30 minutes
  • Patients unable to communicate or assess pain
  • Incomplete clinical records
  • Refusal to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PACU Observational Cohort
This study consists of a single observational cohort of adult patients undergoing elective surgery and subsequently monitored in the post-anesthesia care unit (PACU). No intervention is applied as part of the study. All patients receive standard perioperative care according to institutional clinical practice. Data on analgesic consumption, pain scores, and perioperative variables are collected prospectively to evaluate factors influencing analgesic requirements in the early postoperative period.
This is a non-interventional observational study. No experimental intervention is applied. All patients receive routine perioperative care according to institutional clinical practice. The study involves prospective collection and analysis of clinical data related to analgesic consumption and associated factors during the early postoperative period in the post-anesthesia care unit (PACU).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total Analgesic Consumption in the PACU
Time Frame: During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)
Total amount of analgesic medications administered to patients during their stay in the post-anesthesia care unit (PACU). Analgesic consumption will be recorded and standardized (e.g., converted to morphine equivalents if applicable) to allow comparison across patients.
During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity at PACU Admission
Time Frame: At PACU admission (within the immediate postoperative period)
Pain intensity assessed at admission to the post-anesthesia care unit (PACU) using a standardized pain scale (e.g., Visual Analog Scale or Numeric Rating Scale, 0-10, where 0 indicates no pain and 10 indicates worst imaginable pain).
At PACU admission (within the immediate postoperative period)
Pain Intensity at PACU Discharge
Time Frame: At PACU discharge (within approximately 0-4 hours postoperatively)
Pain intensity assessed at discharge from the post-anesthesia care unit (PACU) using a standardized pain scale (e.g., Visual Analog Scale or Numeric Rating Scale, 0-10).
At PACU discharge (within approximately 0-4 hours postoperatively)
Requirement for Rescue Analgesia in the PACU
Time Frame: During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)
Need for additional rescue analgesic treatment during PACU stay, recorded as whether rescue analgesia was required.
During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)
Incidence of Postoperative Nausea and Vomiting in the PACU
Time Frame: During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)
Occurrence of postoperative nausea and/or vomiting during PACU stay, recorded based on routine clinical assessment.
During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)
Length of Stay in the PACU
Time Frame: During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)
Duration of time spent in the post-anesthesia care unit, measured in minutes from PACU admission to discharge.
During PACU stay (from admission to discharge, within approximately 0-4 hours postoperatively)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 5, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 20, 2026

Study Registration Dates

First Submitted

April 17, 2026

First Submitted That Met QC Criteria

April 17, 2026

First Posted (Actual)

April 23, 2026

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 26, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared due to institutional data protection policies and the need to maintain patient confidentiality. All data collected in this study will be anonymized and used solely for the purposes of this research.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on Observational Assessment

Subscribe